These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 5147770

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of intractable pulmonary tuberculosis].
    Azuma Y.
    Iryo; 1971 Nov; 25(11):827-32. PubMed ID: 5147771
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effectiveness of intravenous chemotherapy in the complex treatment of pulmonary tuberculosis].
    Zits VR.
    Probl Tuberk; 1973 Nov; 51(10):85-6. PubMed ID: 4784047
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Introduction of antibacterial drugs into the pulmonary artery in the treatment of patients with extensive forms of tuberculosis].
    Kuziukovich PM, Shchukin MI.
    Probl Tuberk; 1973 Nov; 51(1):27-30. PubMed ID: 4727154
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Insufflation and instillation of antitubercular drugs into the cavern by the method of maximum concentration].
    Bondarev IM, Ertli AA, Zhigalina LI, Arkatsev TV.
    Probl Tuberk; 1975 Nov; (4):17-22. PubMed ID: 1187585
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Intravenous chemotherapy of newly detected destructive pulmonary tuberculosis].
    Shcherbakov AI.
    Probl Tuberk; 1975 Nov; (8):42-6. PubMed ID: 1208459
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of patients with newly identified destructive forms of pulmonary tuberculosis by using single diurnal doses of tuberculostatics].
    Gerasimov AI, Ganushchak MM, Stakhno LI, Koz'menko LN.
    Probl Tuberk; 1973 Nov; 51(1):20-2. PubMed ID: 4727153
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum hexosamine, iron, and total iron-binding capacity during drug treatment of pulmonary tuberculosis.
    Tani P, Kokkola K.
    Scand J Respir Dis Suppl; 1972 Nov; 80():143-51. PubMed ID: 4510911
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pathogenetic drugs in the treatment of destructive pulmonary tuberculosis in adolescents and adults].
    Buĭko RG, Maksimova NM.
    Probl Tuberk; 1984 Jan; (1):45-9. PubMed ID: 6422459
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of pulmonary tuberculosis: state of the art, 1978.
    Anderson HR.
    J Tenn Med Assoc; 1978 Sep; 71(9):647-50. PubMed ID: 703307
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic effect of ofloxacin on 'treatment-failure' pulmonary tuberculosis].
    Tsunekawa H, Miyachi T, Nakamura E, Tsukamura M, Amano H.
    Kekkaku; 1987 Sep; 62(9):435-9. PubMed ID: 3480971
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.